Related Experiment Video
Updated: May 7, 2026
05:32
Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model
Published on: August 11, 2023
Mutations and polymorphisms in FSH receptor: functional implications in human reproduction
Swapna S Desai1, Binita Sur Roy, Smita D Mahale
1Division of Structural Biology.
Reproduction (Cambridge, England)
|September 21, 2013
Summary
Genetic alterations in the Follicle-Stimulating Hormone Receptor (FSHR) gene impact fertility. Understanding these FSHR gene variations aids in diagnosing infertility and personalizing reproductive treatments.
Area of Science:
- Reproductive Endocrinology
- Molecular Genetics
- Pharmacogenetics
Background:
- The Follicle-Stimulating Hormone Receptor (FSHR) is vital for reproductive functions in both sexes.
- Genetic variations in FSHR, including mutations and polymorphisms, are linked to infertility.
- Understanding FSHR function is key to reproductive health.
Purpose of the Study:
- To review current knowledge on genetic alterations in the FSHR gene.
- To explore the impact of these alterations on FSHR function and female infertility.
- To discuss the implications for personalized reproductive medicine.
Main Methods:
- Analysis of identified inactivating and activating mutations, single nucleotide polymorphisms, and spliced variants of the FSHR gene.
- Genotype-phenotype correlation studies.
- In vitro functional characterization of FSHR mutants compared to wild-type (WT) receptors.
Main Results:
- Genetic variations in FSHR have been identified in infertile individuals.
- Mutant FSHR properties differ from WT, aiding in understanding infertility mechanisms.
- FSHR gene polymorphisms correlate with variable clinical outcomes in FSH-treated women.
Conclusions:
- Genetic alterations in FSHR significantly impact female reproductive function and fertility.
- FSHR genotype-phenotype correlations provide insights into infertility causes.
- Pharmacogenetics of FSHR holds promise for tailored fertility treatments and optimizing ovarian stimulation.
Related Concept Videos
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:57Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
01:39Mutations
Overview